Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06852378

Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ain Shams University

Cairo, 11591, Egypt

Location status: Recruiting

Location contact

Adel M Al Ansary, MD

SUB_INVESTIGATOR

Hazem K Saeed, Master

CONTACT

[email protected]

00201016056123

Ibrahim M El-sherif, MD

SUB_INVESTIGATOR

Mohamed I Shahata, MD

SUB_INVESTIGATOR

Rania H Abdelhafiez, MD

SUB_INVESTIGATOR

About this study

Hip fractures are among the most frequent fractures seen in the emergency department and orthopedic trauma teams. The terms hip fracture and neck of femur fracture are used synonymously. Both terms describe a proximal femur fracture between the femoral head and 5 cm distal to the lesser trochanter.

Iliopsoas nerve Block (IPB) is a promising motor-sparing analgesic technique that selectively targets the sensory branches of the hip joint originating from the femoral nerve and accessory obturator nerve, sparing the motor supply of quadriceps muscles.

A femoral nerve block (FNB) is a simple nerve block that can be performed easily without or under ultrasound guidance. Under ultrasound guidance, the femoral artery and femoral nerve were identified clearly, and a needle was inserted using an in-plane approach from the lateral to the medial direction. Once the needle tip's position was confirmed, 10 ml of 0.5% bupivacaine was injected adjacent to the femoral nerve.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age from 18 to 65 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I and II.
  • Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty.

Exclusion criteria

  • Refusal to participate.
  • Coagulopathy.
  • Patients with a history of drug allergies to study drugs.
  • Inability to cooperate.

Treatment and study plan

Iliopsoas nerve block

Drug

Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

Other names: Bupivacaine 0.5%

Femoral Nerve Block

Drug

Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Other names: Bupivacaine 0.5%

Primary outcomes

  1. Degree of pain

    Time frame: 24 hours postoperatively

    Each patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS) score. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable"). NRS will be assessed upon arrival at the post-anesthesia care unit (PACU) and at 2, 4, 6,12, 24 post-surgery.

Secondary outcomes

  1. Total opioids consumption

    Time frame: 24 hours postoperatively

    Intravenous pethidine (25mg) will be given to be repeated after 15 min if no response up to a maximum dose of 50 mg In case of moderate to sever pain.

  2. Assessment of quadriceps strength

    Time frame: 24 hours postoperatively

    The quadriceps strength will be assessed using the manual muscle testing (MMT) grade (0-5; 0: no muscle contraction, 1: muscle contraction present but unable move joint, 2: able to move joint but not resist gravity, 3: able to resist gravity but not bear substantial resistance, 4: able to resist some level of substantial resistance, 5: able to resist full resistance).

  3. Time of ambulation

    Time frame: 24 hours postoperatively

    Time of ambulation will be recorded from the end of surgery till walking or moving from place to place

  4. Patients' satisfaction

    Time frame: 24 hours postoperatively

    Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied)

  5. Incidence of complications

    Time frame: 24 hours postoperatively

    Any complication will be recorded.

Study contacts

Contact information is provided by the study sponsor or research team.

Hazem K Saeed, Master

CONTACT

[email protected]

00201016056123

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Comparison Between Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Feb 28, 2025
Registry last updated
Mar 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.